NeuroPace Inc NPCE

4d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

NeuroPace Announces Record Full Year 2023 Revenue of $65.4 Million

1mon ago, source: Business Insider

March 05, 2024 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today reported financial results for ...

NeuroPace to Present at the Needham 23rd Annual Healthcare Conference

24d ago, source: Yahoo Finance

MOUNTAIN VIEW, Calif., March 27, 2024 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced ...

OrbiMed Advisors sells shares in NeuroPace worth over $238,000

1d ago, source: Investing

OrbiMed Advisors LLC, a significant shareholder in NeuroPace Inc (NASDAQ:NPCE), has recently sold shares in the medical device company. According to the latest regulatory filings, the investment ...

NeuroPace Announces Chief Legal Officer Irina Ridley’s Departure

2mon ago, source: TipRanks on MSN

Irina Ridley is stepping down as Chief Legal Officer and Corporate Secretary of NeuroPace, Inc., with her departure set for ...

The Latest Analyst Ratings For NeuroPace

1mon ago, source: Business Insider

Unveiling the Story Behind NeuroPace NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the ...

NeuroPace (NASDAQ: NPCE)

10d ago, source: The Motley Fool

NeuroPace, Inc. develops, manufactures, and markets implantable devices for treating epilepsy and neurological disorders. It offers implantable components, which include the RNS neurostimulator as ...

Q4 2023 Neuropace Inc Earnings Call

1mon ago, source: Yahoo Finance

Rebecca Khun; Chief Financial Officer & Vice President, Finance and Administration; Neuropace Inc Frank Takkinen; Analyst; Lake Street Capital Markets Vik Chopra; Analyst; Wells Fargo Mike Kratky; ...

NeuroPace, Inc. (NPCE)

3d ago, source: Yahoo Finance

March 27, 2024 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced it will present at the ...

NeuroPace Announces Record Full Year 2023 Revenue of $65.4 Million

1mon ago, source: Stockhouse

March 05, 2024 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today reported financial results for the ...

NeuroPace, Inc.: NeuroPace Announces Record Full Year 2023 Revenue of $65.4 Million

1mon ago, source: Finanznachrichten

March 05, 2024 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today reported financial results for ...